029-83533393
   info@TaiBSbio.com
 
组织芯片，组织微阵列
多器官
头颈部
口腔
软组织(肌肉脂肪血管等)
皮肤
黑色素瘤
淋巴瘤
脑
心脏
鼻咽和喉
肺
骨和软骨
骨髓
食道
胃
小肠
结肠
直肠
肝
胰腺
阑尾
肾脏
尿道膀胱
甲状腺
肾上腺
胸腺
淋巴结
脾
乳腺
卵巢
输卵管
子宫及内膜
子宫颈
外阴 (阴唇)
前列腺
睾丸
阴茎
间皮
转移癌
胚胎瘤
胎儿
寄生虫
猴子 -恒河猴
猴子 -食蟹猴,
狗
大鼠
小鼠
其它
免疫系统
 
FUR481子宫内膜癌组织芯片，附病理分级、TNM和临床分期，48例/48点
点 数48例 数48
行 数6列 数8
点直径(mm)2.0厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.
产品名:FUR481
 
子宫内膜癌组织微阵列芯片，包含腺癌48例，一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Ute
-Uterus
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (II)
 
Malignant (IIIA)
 
Malignant (IIIC1)
TISSUE  ARRAYS FUR481
1
2
3
4
5
6
7
8
A
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
B
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
C
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
D
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
E
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
F
UTE
UTE
UTE
UTE
UTE
UTE
UTE
UTE
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1159FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant2*1.5*1N
A2270FUterusEndometrioid adenocarcinoma1T1bN0M0IBMalignant3*3*3N
A3347FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant*N
A4452FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant*N
A5545FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant*N
A6647FUterusEndometrioid adenocarcinoma1T1aN0M0IAMalignant*N
A7752FUterusEndometrioid adenocarcinoma2T3aN0M0IIIAMalignant5*5*1N
A8871FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant4*2.5N
B1952FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
B21045FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant*N
B31155FUterusEndometrioid adenocarcinoma2T2N0M0IIMalignant5*2N
B41245FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
B51357FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
B61449FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant10*6*2N
B71550FUterusEndometrioid adenocarcinoma (sparse)2T1bN0M0IBMalignant5*4*0.5N
B81664FUterusEndometrioid adenocarcinoma2T2N0M0IIMalignant3*0.6N
C11753FUterusEndometrioid adenocarcinoma2T3aN0M0IIIAMalignant7*6*4N
C21855FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant6*6*4N
C31960FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant5*5*3N
C42045FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant10*7*5N
C52156FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant6*4.5*1.5N
C62246FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant4.5*4.0*1N
C72335FUterusEndometrioid adenocarcinoma2T1bN0M0IBMalignant3.5*3.0*1.5N
C82443FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant5.0*4.0*1.5N
D12548FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
D22645FUterusEndometrioid adenocarcinoma (sparse)2T1bN1M0IIIC1Malignant*N
D32753FUterusEndometrioid adenocarcinoma2T1aN0M0IAMalignant*N
D42865FUterusEndometrioid adenocarcinoma with necrosis2--3T1bN0M0IBMalignant6*4N
D52938FUterusEndometrioid adenocarcinoma2--3T1bN0M0IBMalignant3*3*2N
D63055FUterusEndometrioid adenocarcinoma2--3T1bN0M0IBMalignant12*6*6N
D73163FUterusEndometrioid adenocarcinoma with necrosis2--3T3aN0M0IIIAMalignant*N
D83252FUterusEndometrioid adenocarcinoma2--3T1bN1M0IIIC1Malignant*N
E13343FUterusEndometrioid adenocarcinoma with necrosis2--3T1bN0M0IBMalignant*N
E23448FUterusEndometrioid adenocarcinoma with necrosis2--3T1aN0M0IAMalignant*N
E33543FUterusEndometrioid adenocarcinoma with necrosis2--3T1aN0M0IAMalignant*N
E43642FUterusEndometrioid adenocarcinoma2--3T1aN0M0IAMalignant3*2.5*1N
E53753FUterusEndometrioid adenocarcinoma2--3T1bN0M0IBMalignant7*6*1.3N
E63858FUterusEndometrioid adenocarcinoma with necrosis3T3N1M0IIIC1Malignant3*2N
E73945FUterusEndometrioid adenocarcinoma3T1bN1M0IIIC1Malignant*N
E84054FUterusEndometrioid adenocarcinoma with necrosis3T1bN0M0IBMalignant6*4.5*1N
F14154FUterusEndometrioid adenocarcinoma (sparse)3T1aN0M0IAMalignant6*4.5*1N
F24242FUterusEndometrioid adenocarcinoma3T1bN0M0IBMalignant3.5*3.0*1N
F34348FUterusEndometrioid adenocarcinoma3T1aN0M0IAMalignant*N
F44445FUterusEndometrioid adenocarcinoma3T1aN0M0IAMalignant*N
F54538FUterusEndometrioid adenocarcinoma3T3aN0M0IIIAMalignant5*4*3N
F64658FUterusEndometrioid adenocarcinoma with necrosis3T2N1M0IIIC1Malignant*N
F74764FUterusEndometrioid adenocarcinoma with necrosis3T1aN0M0IAMalignant4*4N
F84835FUterusEndometrioid adenocarcinoma3--4T3aN0M0IIIAMalignant*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址：陕西西安市灞桥区长乐东路2999号
电话：029-83533393, 17792711553,
电子邮箱：taibsbio@163.com
QQ:3144647811
微信号：13002913390
邮政编码：710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售，加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队，并且具有庞大的组织标本库。样本库中组织微阵列种类多，病理类型齐全，同时根据客户需求情况进行制作加工新的组织微阵列，尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度，致力于为广大客户提供质量好的产品和优质的服务。

更多详情